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Abstract
Background: Suicidal ideation is common in patients suffering from panic disorder. The present study investigated
rates of suicidal ideation and risk factors for suicidal ideation in a sample of primary care patients suffering from
panic disorder with or without agoraphobia.
Methods: A total of N = 296 patients [n = 215 (72.6%) women; age: M = 43.99, SD = 13.44] were investigated.
Anxiety severity, anxiety symptoms, avoidance behavior, comorbid depression diagnosis, severity of depression, age,
sex, employment status, living situation and frequency of visits at the general practitioner were considered as risk
factors of suicidal ideation.
Results: Suicidal ideation was experienced by 25% of the respondents. In a logistic regression analysis, depression
diagnosis and depression severity emerged as significant risk factors for suicidal ideation. Anxiety measures were
not associated with suicidal ideation.
Conclusion: Suicidal ideation is common in primary care patients suffering from panic disorder with or without
agoraphobia. Individuals with greater burden of mental illness in terms of mood disorder comorbidity and depressive
symptomatology are especially likely to suffer from suicidal ideation.
Keywords: Suicidal ideation, Panic disorder, Agoraphobia, Primary care
Background
Suicidal ideation is highly prevalent in the general
population (8.5%; [1]) and even more in clinical sam-
ples (18–32%; [2]). Thinking about suicide is a risk
factor for completed suicide [3], and even passive
ideation, such as a wish to die, has been identified as a
predictor for death by suicide [4]. Since there is a
rapid transition from suicidal ideation to plans and
attempts [5] early detection of suicidal ideation is es-
sential to initiate timely interventions. A better know-
ledge of risk factors for suicidal ideation, especially in
primary care patients, may therefore help to identify
potentially suicidal patients.
One of the strongest risk factors for suicidal ideation
and behavior is the presence of a mental disorder, most
prominently affective disorders, schizophrenia and sub-
stance use disorders [6], but also anxiety disorders [7].
Among anxiety disorders, panic disorder has received a
great deal of attention: Using data from the National In-
stitute of Mental Health Epidemiologic Catchment Area
(ECA) study, Weissman et al. [8] found that 47% of indi-
viduals with panic disorder reported lifetime suicidal
ideation. In European community studies lower - but
still significant - rates of lifetime suicidal ideation have
been found in persons suffering from panic disorder
(23.7%: [2]; 15.7%: [9]). In studies on treatment-seeking
patients suffering from panic disorder 31% reported
having had suicidal thoughts in the past year [10] and
25% in the past week [11] - even after excluding patients
suffering from comorbid major depression. Taken
together, there is strong evidence that patients suffering
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from panic disorder display heightened risk for suicidal
ideation, which underscores the debilitating character of
the disorder. Yet, most information concerning suicidal
ideation in panic disorder stems from studies on the
general population or psychiatric services [7] and may
not apply to primary care settings.
The prevalence of anxiety disorders is higher in pri-
mary care settings than in the general population [12]
and current panic disorder/agoraphobia diagnoses are
found in about 4% of primary care patients [13]. Men-
tal health care for panic disorder/agoraphobia is
sought and obtained mostly from general practitioners
[14]. Yet, suicidal ideation often goes unrecognized in
these settings [15], even though almost 50% of patients
who died through suicide had seen their general
practitioner in the month preceding their death [16]
and up to 20% visit a primary care provider within 1
day of their death [17]. In light of these findings, pri-
mary care settings have been emphasized as an essen-
tial component of effective and comprehensive suicide
prevention [18].
Therefore, the first aim of this study was to identify
rates of suicidal ideation in primary care patients diag-
nosed with panic disorder with or without agoraphobia.
The second aim was to identify characteristic symp-
toms that are associated with suicidal ideation and may
therefore guide risk assessment in primary care pa-
tients. Anxiety severity, anxiety symptoms, agoraphobic
avoidance as well as depression diagnosis, depression
severity, demographic markers (age, sex, living alone,
unemployment) previously shown to be associated with
suicidal ideation [19], and frequency of visits at the
general practitioner, as an alternative measure of gen-
eral distress, were considered as potential predictors of
suicidal ideation.
Methods
Study design
A cross-sectional study that was nested in a random-
ized trial comparing a practice team-supported, self-
managed exposure program for patients with panic
disorder (PD) with or without agoraphobia (AG) in
general practices to usual care was conducted [Trial
Registration: ISCRTN64669297]. The study was ap-
proved by the Ethics Committee of the Friedrich-
Schiller-University at the Medical Faculty (Jena,
Germany). Details of the study design and recruiting
process have been published previously [20]. To be eli-
gible for the trial, patients had to meet the following
inclusion criteria: (1) being at least 18 years of age, (2)
being diagnosed with PD/AG (ICD-10: F41.0 or
F40.01) by a general practioner-led clinical interview,
(3) showing a minimum total score on the ‘Overall
Anxiety and Impairment Scale’ (OASIS) of 8 points
[21] and at least two positive answers on the panic
module of the ‘Patient Health Questionnaire’ (PHQ;
[22]) at the time of inclusion, (4) having sufficient Ger-
man language skills, (5) having a telephone connection,
(5) being able of giving written informed consent to
participate in the study. Patients were excluded if they
met one or more of the following exclusion criteria ac-
cording to general practitioner’s clinical evaluation: suf-
fering from suicidal tendencies in need of immediate
treatment, acute or chronic psychosis, dependence on
psychoactive substance(s), or severe physical illness, be-
ing pregnant, receiving professional psychotherapeutic
treatment for their anxiety disorder at the time of in-
clusion. Of note, none of the patients screened for the
study was excluded due to suicidal tendencies in need
of immediate treatment. Data collection occurred be-
tween August 2012 and October 2014.
Participants
At baseline, a sample of 419 patients took part in an ex-
haustive assessment. The full set of questionnaires was
completed by 296 patients [n = 215 (72.6%) women; age:
M = 43.99, SD = 13.44] and only patients who completed
all questionnaires were included in the current analysis.
Patients with complete data and patients who completed
only a subset of questionnaires did neither differ in sex
nor diagnosis. However, patients who completed only a
subset of questionnaires were older than patients with
complete data, t(414) = 5.23, p < .000.
Half of the patients were married (n = 150; 50.6%),
33.4% were singles (n = 99), 11.8% were separated/di-
vorced (n = 35) and 4.1% were widowed (n = 12). A
minority of patients was unemployed (n = 41, 13.6%).
The vast majority (n = 231, 78%) suffered from panic
disorder with agoraphobia, and n = 65 (22%) from panic
disorder without agoraphobia. Fifty-five individuals
(18.6%) suffered from a comorbid depressive disorder.
Most patients saw their general practitioner on a very
regular basis, with M = 8.76 (SD = 8.72) visits within the
last 6 months. All participants were Caucasian.
Measures
Suicidal ideation
Suicidal ideation was measured using the respective
item from the Patient Health Questionnaire’ (PHQ-9;
[22]): “Over the last two weeks, how often have you
been bothered by thoughts that you would be better of
dead, or of hurting yourself in some way?” Response
options range from “not at all”, “several days”, “more
than half the days” to “nearly every day”. Response to
the PHQ-9-suicide item has recently been shown to be
a strong predictor of suicide attempt and suicide death
within the following year [23].
Teismann et al. BMC Psychiatry  (2018) 18:305 Page 2 of 5
Anxiety symptoms
Anxiety Symptoms were measured with the Beck Anx-
iety Inventory (BAI; [24]). The BAI is a 21-item self-re-
port measure that surveys anxiety symptoms on a
4-point severity scale. It has demonstrated good internal
consistency (Cronbach’s α ≥ .85 across clinical and
non-clinical samples [25]). The internal consistency for
the BAI in the current sample was α = .91.
Anxiety severity
The Overall Anxiety Severity and Impairment Scale
(OASIS; [26]) is a 5-item self-report measure to assess
frequency and intensity of anxiety symptoms, functional
impairment related to these symptoms and behavioral
avoidance. All items are answered on a 5-point scale
ranging from 0 (not at all) to 4 (extreme). The OASIS
has a unidimensional factor structure and has been
shown to have a good internal consistency (Cronbach’s
α = .89) as well as convergent and divergent validity [21].
Internal consistency was rather modest in the current
sample: α = .67.
Agoraphobic avoidance
The ‘Mobility Inventory’ (MI; subscale ‘alone’; [27]) was
used to assess agoraphobic avoidance behavior across a
variety of different situations. All items are answered on a
5-point scale ranging from 1 (never) to 5 (always). The
MI-total score has an excellent internal consistency: Cron-
bach’s α ≥ .94 [27]. Accordingly, internal consistency was
good in the present sample: α = .95.
Depressive symptoms
Severity of depressive symptoms was measured by the
‘Patient Health Questionnaire’ (PHQ-[9, 22]). The PHQ-
9 assesses the occurrence of nine depressive symptoms
within the previous 2 weeks. It has been shown to have
good internal consistency: Cronbach’s α ≥ .86 [28]. In-
ternal consistency was α = .84 in the present sample.
The suicide item was excluded from the PHQ-sum score
to avoid overlapping and thus part-whole correlations.
Statistical analyses
We conducted bivariate correlation analyses (Spear-
man) of all study variables. Then, a logistic regression
analysis was performed with suicidal ideation (yes/no)
as criterion. Age, sex, current unemployment (yes/no),
living status (living alone: yes/no), frequency of visits
at the general practitioner, diagnosis of panic disorder
with vs. without agoraphobia, comorbid depression
disorder (yes/no), depressive symptom severity, anx-
ious symptoms, anxiety severity and avoidance behav-
ior were considered as predictors of suicidal ideation.
Derived odds rations (including 95% confidence inter-
val, CI) are presented for each predictor variable.
Tolerance in the collinearity statistics was higher than
0.2 for all models, indicating the absence of multicolli-
nearity. All statistical analyses were conducted using
the statistical analysis program IBM SPSS Statistics 21
(SPSS Inc., Illinois, Chicago).
Results
Descriptive statistics and correlations
Descriptive statistics for each measure are presented in
Table 1. A quarter of the sample (25%; n = 74) reported
suicidal ideation (i.e., scores > 0 on the PHQ-9 suicide
item) within the last 2 weeks: Sixty-one patients (20.5%)
indicated suffering from suicidal ideation for “several
days” during the last 2 weeks, nine patients (3.1%) indi-
cated that they had suffered from suicidal ideation for
“more than half the days” and four patients (1.4%) indi-
cated suffering from suicidal ideation “nearly every day”.
As shown in Table 1, suicidal ideation correlates
positively with anxiety symptoms, anxiety severity and
depression. However, an association with avoidance be-
havior was not detected.
Risk factors of suicidal ideation
Table 2 shows the results of the logistic regression
analysis with suicidal ideation as criterion variable.
Only comorbid depression disorder and depression
severity predicted concurrent suicidal ideation. Neither
anxiety symptoms nor anxiety severity and avoidance be-
havior emerged as significant predictors.
Discussion
Results of the present study indicate that suicidal idea-
tion is common in primary care patients suffering from
panic disorder with or without agoraphobia. In total,
25% of the patients reported suicidal ideation within the
last 2 weeks. This percentage closely approximates those
from other studies on patient samples suffering from
anxiety disorders [11, 29] and points to the debilitating
character of the disorder. In a logistic regression ana-
lysis, only comorbid depression diagnosis and depression
severity emerged as significant predictors of suicidal
Table 1 Means, standard deviations and correlations of study
variables
M (SD) PHQ-SI
PHQ-SI 0.31 (0.59) –
BAI 28.71 (12.33) .233**
OASIS 12.54 (2.66) .190**
MI 2.28 (0.83) .077
PHQ 11.10 (5.25) .417**
BAI Beck Anxiety Inventory, MI Mobility Inventory, OASIS Overall Anxiety
Severity and Impairment Scale, PHQ Patient Health Questionaire, PHQ-SI
Patient Health Questionaire – Suicide Ideation Item
**= p < .01
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ideation. Anxiety measures were not associated with
suicidal ideation. Furthermore, patients suffering from
panic disorder with agoraphobia were not more likely to
suffer from suicidal ideation than patients suffering from
panic disorder without agoraphobia.
Taken together, the current findings complement previ-
ous research that found depression to be the key risk fac-
tor for suicidal ideation and behavior within samples of
anxiety patients (e.g., [29, 30]). However, the relationship
between panic disorder and suicidal ideation and behavior
remains a controversial one, as some studies found such
an association, even in the absence of coexisting major de-
pression [8]. Furthermore, panic attacks have repeatedly
been shown to be associated with imminent suicide risk
[31, 32]. Against this background the findings of Yaseen et
al. [32] are of particular interest: they report that only fear
of dying within a panic attack is prospectively associated
with suicide attempts, whereas no other panic attack
symptom was associated with subsequent suicidal ideation
and behavior.
In terms of clinical implications, the results of the
current study highlight the importance of suicide risk
assessments in anxiety patients. Though suicide as-
sessments for individuals suffering from depression
has received considerable attention within primary
care (e.g., [33]), findings point to the additional need
for routine suicide risk assessments in patients suffer-
ing from panic disorder [29]. Taken together, general
practitioners should be encouraged to ask about sui-
cidal ideation in their anxiety patients, particularly in
those suffering from comorbid depression.
The strengths of the present investigation are its em-
bedding within the framework of the thoroughly de-
signed Jena-PARADIES study and the use of well-
established depression and anxiety instruments. Yet,
there are some limitations to the current study. First, the
present investigation is a cross-sectional analysis; there-
fore, conclusions on causality cannot be drawn. Second,
suicidal ideation was assessed using a single item self-re-
port measure, instead of a multi-item self-report ques-
tionnaire. Single-item assessment are associated with an
increased risk of misclassification [34]; at the same time,
Simon et al. [23] reported strong evidence for the pre-
dictive ability of the PHQ suicide item [23]. Third, most
patients reported that suicidal ideation would occur only
occasionally. It therefore remains unclear to what extent
results generalize to samples with more intensive sui-
cidal thoughts. Finally, the group of predictors used in
the study was far from exhaustive. In particular, we did
not measure anxiety cognitions or anxiety sensitivity,
both variables that have been associated with suicidal
ideation [32, 35].
Conclusion
The present study showed that suicidal ideation is not
uncommon in primary care patients suffering from panic
disorder with or without agoraphobia. Patients particu-
larly affected are those suffering from comorbid mood
disorders and depressive symptomatology [29].
Acknowledgements
The authors thank all GPs and patients who participated in this study.
Funding
This trial was funded by the German Federal Ministry of Education and
Research (BMBF; grant-number: 01GY1146). The funding source was not
involved in the interpretation of the data, in the writing of the report and in
the decision to submit the article for publication.
Availability of data and materials
The datasets used and/or analysed during the current study are available from
the corresponding author and/or the senior author on reasonable request.
Authors’ contributions
TT and KL wrote a first draft of the current manuscript. TSH, JM and JG were
responsible for the design and conception of the study. TSH, JB, CB were
responsible for the acquisition of data and US for data analysis. All authors
were involved in revising the manuscript critically for important intellectual
content and all authors gave final approval of the current manuscript version
to be published.
Ethics approval and consent to participate
The study was approved by the Ethics Committee of the Friedrich-
Schiller-University at the Medical Faculty (Jena, Germany). Written informed
consent was obtained from all patients before study intake.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests. All authors had
financial support from BMBF for the submitted work; no financial
relationships with any organisations that might have an interest in the
submitted work in the previous 3 years; no other relationships or activities
that could appear to have influenced the submitted work.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published
maps and institutional affiliations.
Table 2 Logistic regression analysis predicting suicidal ideation
OR (95% CI) 21p
Age 1.01 (.99–1.04) n.s.
Sex .83 (.40–1.72) n.s.
Living alone (yes/no) 1.20 (.64–2.61) n.s.
Unemployment (yes/no) .79 (.32–1.96) n.s.
GP-visits 1.02 (.99–1.06) n.s.
PD with AG vs. PD without AG 1.07 (.49–2.35) n.s.
Comorbid depression (yes/no) 2.33 (1.12–4.84) .023
PHQ 1.22 (1.13–1.32) .000
BAI 1.01 (.98–1.04) n.s.
OASIS 1.02 (.90–1.16) n.s.
MI .70 (.45–1.07) n.s.
AG Agoraphobia, BAI Beck Anxiety Inventory, MI Mobility Inventory, GP general
practitioner, OASIS Overall Anxiety Severity and Impairment Scale, PD Panic
disorder, PHQ Patient Health Questionaire
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